Literature DB >> 326671

Interactions of radio-detoxified Escherichia coli endotoxin preparations with the complement system.

G Füst, L Bertók, S Juhász-Nagy.   

Abstract

Escherichia coli O89 lipopolysaccharide (LPS) was treated with different doses of gamma irradiation (5, 10, 15, and 20 Mrad). Various biological activities such as lethal effect, decrease in arterial blood pressure in dogs, and interaction with the complement system were determined for the parent and irradiated preparations. Irradiation of LPS significantly and in a dose-dependent manner decreased its lethal and blood pressure-depressing effects along with its ability to activate the complement system. In contrast, radio-detoxified LPS fixed more strongly the isolated human C1 than did the parent LPS. The possible connection between the toxicity of endotoxin and endotoxin-induced complement activation is discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 326671      PMCID: PMC421482          DOI: 10.1128/iai.16.1.26-31.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  The effect of anticomplementary substances on properdin in normal and C2-deficient sera.

Authors:  R H McLean; K Townsend; A F Michael
Journal:  Clin Exp Immunol       Date:  1975-03       Impact factor: 4.330

2.  Immune hemolysis: a simplified method for the preparation of EAC'4 with guinea pig or with human complement.

Authors:  T Borsos; H J Rapp
Journal:  J Immunol       Date:  1967-08       Impact factor: 5.422

3.  Interactions of the complement system with native and chemically modified endotoxins.

Authors:  H Gewurz; S E Mergenhagen; A Nowotny; J K Phillips
Journal:  J Bacteriol       Date:  1968-02       Impact factor: 3.490

4.  Activation of the classic and alternate complement pathways by endotoxin.

Authors:  D P Fine
Journal:  J Immunol       Date:  1974-02       Impact factor: 5.422

5.  Activation by some T-independent antigens and B cell mitogens of the alternative pathway of the complement system.

Authors:  D Bitter-Suermann; U Hadding; H U Schorlemmer; M Limbert; M Dierich; P Dukor
Journal:  J Immunol       Date:  1975-08       Impact factor: 5.422

6.  Physical state and biological activity of lipopolysaccharides. Toxicity and immunogenicity of the lipid A component.

Authors:  C Galanos
Journal:  Z Immunitatsforsch Exp Klin Immunol       Date:  1975-07

7.  Influence of the alternate complement pathway in opsonization of several bacterial species.

Authors:  A Forsgren; P G Quie
Journal:  Infect Immun       Date:  1974-08       Impact factor: 3.441

8.  C1 fixation and classical complement pathway activation by a fragment of the Cmu4 domain of IgM.

Authors:  M M Hurst; J E Volanakis; R M Stroud; J C Bennett
Journal:  J Exp Med       Date:  1975-11-01       Impact factor: 14.307

9.  Mediation systems in bacterial lipopolysaccharide-induced hypotension and disseminated intravascular coagulation. I. The role of complement.

Authors:  R J Ulevitch; C G Cochrane; P M Henson; D C Morrison; W F Doe
Journal:  J Exp Med       Date:  1975-12-01       Impact factor: 14.307

10.  Formation of C3a and C5a anaphylatoxins in whole human serum after inhibition of the anaphylatoxin inactivator.

Authors:  E H Vallota; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1973-05-01       Impact factor: 14.307

View more
  4 in total

1.  The relationship between the binding ability and the rate of activation of the complement component C1.

Authors:  E J Folkerd; B Gardner; N C Hughes-Jones
Journal:  Immunology       Date:  1980-09       Impact factor: 7.397

2.  Naturally occurring hypothermia is more advantageous than fever in severe forms of lipopolysaccharide- and Escherichia coli-induced systemic inflammation.

Authors:  Elaine Liu; Kevin Lewis; Hiba Al-Saffar; Catherine M Krall; Anju Singh; Vladimir A Kulchitsky; Joshua J Corrigan; Christopher T Simons; Scott R Petersen; Florin M Musteata; Chandra S Bakshi; Andrej A Romanovsky; Timothy J Sellati; Alexandre A Steiner
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-04-18       Impact factor: 3.619

3.  Muramyl dipeptide is a powerful potentiator of the antitumor action of various tumor-necrotizing agents.

Authors:  N Bloksma; F M Hofhuis; J M Willers
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

4.  Variant O89 O-Antigen of E. coli Is Associated With Group 1 Capsule Loci and Multidrug Resistance.

Authors:  Susan Harris; Marta J Piotrowska; Robert J Goldstone; Ruby Qi; Geoffrey Foster; Ulrich Dobrindt; Jean-Yves Madec; Charlotte Valat; Francesco V Rao; David G E Smith
Journal:  Front Microbiol       Date:  2018-08-31       Impact factor: 5.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.